BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath.
BOYDSense has raised $7.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
BOYDSense's investors include European Innovation Council, Jolt Capital, BioSerenity, Alpha MOS, Ambrosia Investments.
BOYDSense is headquartered in South San Francisco, United States.
BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath.
BOYDSense is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BOYDSense — Funding & Investors." VCBacked, April 5, 2024, https://www.vcbacked.co/company/boydsense. Accessed July 20, 2026.
VCBacked. (2024). BOYDSense — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/boydsense
{{cite web |title=BOYDSense — Funding & Investors |url=https://www.vcbacked.co/company/boydsense |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated